Why Are ADHD and Autism Showing Up More Often in Young People With Type 2 Diabetes?

Why do ADHD and autism appear more often among young people diagnosed with type 2 diabetes? New research presented at the European Association for the Study of Diabetes meeting offers an important clue, but not a simple cause-and-effect answer. The association between neurodiversity and type 2 diabetes was strongest among people diagnosed at younger ages. However, the findings do not show that ADHD or autism causes type 2 diabetes. Instead, they highlight a group that may benefit from diabetes care designed around different communication, organization, and self-management needs.

Table of Contents

• What the EASD study found
• Why neurodiversity may matter in diabetes care
• How clinicians can adapt education and follow-up
• What the research does and does not prove
• Conclusion
• FAQs

What EASD Research Found About Neurodiversity and Type 2 Diabetes

Researchers analyzed electronic health records from the TriNetX U.S. collaborative network. The study included millions of people newly diagnosed with type 2 diabetes and compared them with matched individuals who did not have the condition. Researchers matched participants by factors including age, sex, race, and ethnicity.

The differences were especially noticeable among younger patients. Among people diagnosed with type 2 diabetes before age 20, ADHD was substantially more common than in matched individuals without diabetes. Autism was also more frequently documented in the group with type 2 diabetes.

According to reports on the EASD findings, ADHD prevalence in the youngest group was 14.4% among those with type 2 diabetes compared with 6.9% among those without it. Autism was recorded in 5.72% of people with type 2 diabetes compared with 1.79% of matched controls.

These differences generally became smaller as the age at diabetes diagnosis increased. Other neurodevelopmental conditions, including dyslexia and dyspraxia, were also more common in some groups with type 2 diabetes.

Still, the findings linking neurodiversity with type 2 diabetes were most striking among people diagnosed early in life. That is important because young-onset type 2 diabetes can create a substantial lifetime health burden. Earlier diagnosis can mean more years living with hyperglycemia and other cardiometabolic risk factors.

As a result, clinicians may need to think not only about glucose targets and medications, but also about how younger patients process information, organize daily tasks, and interact with the healthcare system.

Why ADHD and Autism May Affect Diabetes Self-Management

Managing type 2 diabetes involves much more than taking medication. Patients may need to remember appointments, monitor glucose, organize prescriptions, plan meals, stay physically active, and respond to changes in treatment.

For some people with ADHD, planning, time management, sustained attention, and remembering repetitive tasks can be challenging. Therefore, a complicated treatment plan or lengthy education session may create unnecessary barriers.

For example, a patient may understand exactly why medication is important but still struggle to take it consistently at the same time each day. Likewise, missed appointments may reflect organizational difficulties rather than a lack of interest in treatment.

Autistic patients may face different challenges. Some people experience sensory sensitivities, communication differences, difficulty with unexpected changes, or a strong preference for predictable routines. Consequently, busy clinics, unfamiliar staff, changing instructions, or vague follow-up plans may make diabetes care harder to navigate.

These differences do not mean neurodivergent patients cannot successfully manage diabetes. Instead, they suggest that standard diabetes education may work better when clinicians adapt it to individual needs.

The conversation around neurodiversity and type 2 diabetes is therefore less about labeling patients and more about designing care that people can realistically use.

Structured diabetes education may be especially valuable when it includes short instructions, visual aids, clear routines, repetition, and specific next steps. In many cases, a simple checklist may be more useful than a long verbal explanation.

How Diabetes Care Can Better Support Neurodivergent Patients

Small changes in clinical practice may make diabetes care easier to understand and follow. Clinicians can begin by asking patients how they prefer to receive information. Some may benefit from written instructions, while others may prefer visual guides, reminders, or brief conversations focused on one task at a time.

Treatment plans can also be simplified when clinically appropriate. Linking medications to existing routines, such as breakfast or bedtime, may make adherence easier. Phone reminders, pill organizers, glucose monitoring alerts, and scheduled follow-up messages may also help some patients.

In addition, healthcare teams should be cautious about interpreting missed appointments or inconsistent self-care as unwillingness to participate. Instead, clinicians can explore whether attention, executive functioning, sensory concerns, transportation, cost, or communication difficulties are creating barriers.

Clear follow-up instructions are also important. Rather than saying, “Come back in a few months,” clinicians may provide a specific date, explain what will happen at the next visit, and list any laboratory tests or glucose records the patient should bring.

Diabetes education may also be more effective when family members or caregivers are included, when appropriate and with the patient's consent. However, clinicians should continue to address the patient directly and respect individual preferences for communication and independence.

When additional support is needed, coordination with behavioral health professionals, primary care clinicians, diabetes educators, or other specialists may help. Patients seeking professional medical guidance can also explore healthcare resources through Healthcare.pro.

Importantly, current diabetes screening recommendations remain based on established clinical risk factors. Neurodivergence alone is not considered a stand-alone indication for type 2 diabetes screening.

What the Link Between Neurodiversity and Type 2 Diabetes Does Not Prove

The EASD research was observational. Therefore, it cannot determine whether ADHD, autism, or other neurodevelopmental conditions directly contribute to the development of type 2 diabetes.

Several factors could help explain the association. Researchers have pointed to possible differences in physical activity, sleep, mental health conditions, medication exposure, healthcare access, and other behavioral or medical factors.

Healthcare contact may also influence diagnosis rates. People who have more frequent contact with clinicians may have more opportunities to receive both metabolic and neurodevelopmental diagnoses. As a result, part of the association could reflect differences in detection.

Previous studies have also reported associations between ADHD and type 2 diabetes. However, other medical and psychiatric conditions may explain part of that relationship. Similarly, earlier research has reported higher rates of type 2 diabetes among some young people with autism.

None of these findings prove that autism or ADHD causes diabetes. Likewise, they do not mean that every neurodivergent young person has an elevated individual risk.

Instead, the research raises important questions about how diabetes and neurodevelopmental conditions may overlap. Future studies will need to examine biological, behavioral, social, and healthcare factors more closely.

For clinicians, the immediate lesson may be practical. When a young person with type 2 diabetes is also neurodivergent, diabetes care may work better when communication, education, and daily routines are tailored to that individual.

Conclusion

The EASD findings reveal a notable overlap between neurodiversity and early-onset type 2 diabetes, particularly among people with ADHD and autism. However, the research shows an association, not causation.

For healthcare professionals, the findings offer an opportunity to make diabetes care more flexible and accessible. Clear communication, predictable follow-up, simplified treatment routines, and individualized diabetes education may help reduce barriers for neurodivergent patients. As research continues, understanding how these conditions intersect could help clinicians provide more effective and patient-centered care.

FAQs

Are ADHD and autism more common in young people with type 2 diabetes?

In the EASD analysis, ADHD and autism were both more commonly documented among people diagnosed with type 2 diabetes at younger ages compared with matched individuals without diabetes.

Does ADHD cause type 2 diabetes?

No causal relationship has been established. The research identified an association, but behavioral, medical, social, and healthcare-related factors may contribute to the relationship.

Does autism increase the risk of type 2 diabetes?

Some observational studies have reported an association between autism and type 2 diabetes. However, researchers still need more evidence to understand why the conditions may overlap.

How can diabetes education better support neurodivergent patients?

Education can be adapted by using clear written instructions, visual information, shorter explanations, reminders, predictable routines, and specific follow-up steps. Clinicians can also ask patients directly which communication methods work best for them.

Should young people with ADHD or autism automatically be screened for type 2 diabetes?

Current screening guidance is based on established diabetes risk factors. ADHD or autism alone is not generally considered a stand-alone reason for type 2 diabetes screening.

This content is not medical advice. For any health issues, always consult a healthcare professional. In an emergency, call 911 or your local emergency services.